Share

CEO Dr Nick New speaks to MIT Technology Review

Nick New

Earlier this week, Optalysys CEO, Dr Nick New, spoke to MIT Technology Review about how optical processing technology could transform genomics.  Optalysys is currently building an optical co-processor product for the bioinformatics market through a collaboration project (Project GENESYS) with the Earlham Institute (formerly The Genome Analysis Centre).  In the article, Dr New also describes why now is the right time for optical processing technology to come to market and covers some of the other focus areas where Optalysys is applying their technology.

Read full article

 

About Optalysys:

Optalysys was founded in 2013.  CEO Dr Nick New, a renowned world expert in optical pattern recognition, developed the forerunner to the Optalysys technology whilst carrying out his PhD on optical pattern recognition at Cambridge University. Dr New went on to forge relationships with international academic and commercial institutions before securing funding to take Optalysys forward.

The Optalysys team includes specialists in software development, Computational Fluid Dynamics (CFD), free-space optics, optical engineering and production engineering.

The company has several patents covering its groundbreaking technology.

Latest news view all
Software Engineer joins Optalysys

Optalysys welcomes Software Engineer Omri Kalinsky to the team based in Nevada, USA. Omri has been a professional software engineer since 1998. He has a varied background of applications ranging from medical imaging, military simulation and games to business and productivity software, embedded systems and mobile applications. He has specific expertise in C++ including developing and teaching C++ […]

read more
March 2017 Newsletter

Welcome to the Optalysys March 2017 Newsletter – your regular update on the latest developments in optical computing.  In this edition we cover our participation at the Advances in Genome Biology and Technology (AGBT) conference in Miami, Florida USA, our appointment of a seasoned bioinformatics expert to head up business development for North America, details on our new U.S. office in Reno, Nevada, […]

read more
Optalysys Inc moves to new office in Reno, Nevada USA

Optalysys Inc, the wholly owned US subsidiary of Optalysys Ltd, has moved office to a larger space in Reno, Nevada USA to support the growing US team. Our new address is: 200 S Virginia St, 8th Floor Reno, NV 89501 USA   About Optalysys: Optalysys was founded in 2013 to develop revolutionary optical processing technology […]

read more
Bioinformatics business development expert joins Optalysys

Optalysys welcomes Martin Gollery to the Business Development team based in Nevada, USA. Martin has joined as VP of Business Development for North America and will focus initially on building relationships with bioinformatics customers and partners. Martin has been in Bioinformatics for 19 years. He co-founded the Nevada Center For Bioinformatics, is the author of several […]

read more